Blume Forte secured a jury verdict in an Atlantic County wrongful death case on behalf of a 25-year-old woman who died from choriocarcinoma, an aggressive but typically curable pregnancy-related cancer. The plaintiff alleged that three OB-GYNs misdiagnosed her bleeding as a miscarriage, failed to examine her or consider other causes, and delayed diagnosis by a month, allowing the cancer to spread. Despite extensive treatment, the woman died, leaving behind a 1.5-year-old child.
A $3.5 million settlement was obtained for a 28-year-old woman whose doctors failed to timely diagnose her breast cancer after repeatedly misdiagnosing a breast lump as cystic breast disease. Appropriate testing, including mammography and biopsy, was not ordered, delaying diagnosis until the cancer had advanced and significantly reduced her chances of full recovery.
This case resulted in a $2.2 million recovery during trial for a woman whose breast cancer was not timely diagnosed after mammograms were misread over multiple years. Earlier imaging revealed increasing microcalcifications that were not properly identified or communicated, delaying diagnosis until the cancer had advanced and significantly reducing her chances of survival.
Blume Forte secured a $2 million settlement in a failure-to-diagnose lung cancer case involving a woman with scleroderma. A lung lesion seen on CT was mistakenly assumed to be related to her autoimmune disease, and recommended follow-up and biopsy were not performed, delaying diagnosis by 18 months. The cancer was ultimately fatal, despite defense claims that her prognosis was poor regardless of the delay.
This matter involved a woman whose cervical cancer went undiagnosed until it had spread and was no longer curable. The delay in diagnosis prevented timely treatment and ultimately led to her death. The case resolved for $2 million on behalf of her estate.
Blume Forte represented a young woman whose breast cancer was missed after an ultrasound was misread and the gynecologist dismissed her concerns, attributing the lump to a dilated duct from breastfeeding. No follow-up testing was ordered, and 17 months later the cancer had metastasized to her bones. The case settled against both the radiologist and gynecologist for a total of $1.85 million.
In this case, errors in interpreting mammography studies and failures in follow-up care delayed a woman’s breast cancer diagnosis until it reached Stage IV. The disease progressed significantly before detection, and the family ultimately recovered $1.8 million for the harm caused by the delayed diagnosis.
A mother of two sought medical care for ulcer-like symptoms, but earlier gastrointestinal studies showing signs of stomach cancer were missed. An 18-month delay in diagnosis allowed the disease to progress unchecked, resulting in her death. The family recovered $1.65 million.
This case involved a delay of approximately two and a half years in diagnosing ductal breast cancer. During that time, the cancer progressed to Stage III and later spread to other areas of the body. The matter resolved with a $1.6 million settlement.
Physicians failed to inform a man that imaging ordered for an unrelated injury showed signs of lung cancer. The lack of follow-up delayed treatment for nearly 20 months, allowing the disease to progress and worsening his prognosis. He later died from lung cancer, and the case settled for $1.6 million.
Despite multiple abnormal PSA test results over several years, no further diagnostic action was taken. The delayed diagnosis allowed prostate cancer to spread beyond the prostate, significantly reducing the patient’s long-term survival outlook. The case resulted in a $1.5 million settlement.
A screening colonoscopy failed to detect colon cancer despite the patient’s symptoms and family history. More than two years later, advanced-stage cancer was discovered. Following a trial, the jury awarded $1.5 million to the family after the patient died from metastatic disease.
Abnormal diagnostic findings were overlooked when a patient presented with abdominal and bowel complaints. No additional testing was ordered, and the cancer was not diagnosed until it reached Stage IV years later. The delayed diagnosis ultimately led to the patient’s death, and the family recovered $1.25 million.
A patient with known risk factors for liver cancer had imaging that revealed a liver mass, but no appropriate follow-up testing was ordered. The delay in diagnosis allowed the cancer to become terminal. After years of litigation, the case resolved for $1 million.
Following an abnormal Pap smear during pregnancy, appropriate follow-up testing was never scheduled. The failure to repeat testing after delivery delayed diagnosis until the cancer had progressed to Stage IV. The case resulted in a $1 million settlement.
What to Expect
VIEW
( 01 )